Ecron Acunova CRO Expands its Clinical Research Center for Drug Development
This expansion caters to the growing needs of its global clients in Pharmaco-Kinetic and Pharmaco Dynamic studies. This takes total bed capacity to 176 units in research centers at Mangalore, Manipal, and Bangalore. Drug research involves analyzing the activity of the drug in plasma using spectroscopy. Highly sophisticated spectrometers have been added. Speaking on the occasion Dr. Ramdas Pai said, "I commend the safe conduct of studies for Indian and global companies, leveraging the scientific and clinical talent of India. It is heartening to note that studies conducted at the center, got US FDA approval, leading to launch of drugs for treatment of HIV, cancer etc."
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025